The Price of Admission: Licensee Challenges to Patents After Medimmune v. Genentech

Name: The Price of Admission: Licensee Challenges to Patents After Medimmune v. Genentech
Cite: 51-JUN BBJ 10
Year: 2007
Bluebook cite: Erik Belt and Keith Toms, The Price of Admission: Licensee Challenges to Patents After Medimmune v. Genentech, 51 Boston Bar Journal 10 (May/June 2007)
Author: Erik Belt and Keith Toms
URL
Item Type: article
Summary: Analysis of the Medimmune decision. Authors conclude that Medimmune does not eliminate the consequences of challenging a licensing agreement.

...more